Substance Use Disorder (SUD) Outpatient Treatment Services Level 1-2

The District of Columbia is seeking proposals for Substance Use Disorder (SUD) Outpatient Treatment Services at Level 1-2, with a solicitation posted on May 22, 2024, and proposals due by June 10, 2024. This procurement aims to secure comprehensive substance abuse treatment services for individuals requiring outpatient care, with a focus on structured therapeutic interventions and rehabilitation support. The contract will require providers to deliver evidence-based treatment protocols, including individual and group counseling, medication-assisted treatment, and comprehensive case management for patients with substance use disorders. Qualified vendors must demonstrate extensive clinical expertise in addiction treatment, possess appropriate state licensing, and have documented experience managing outpatient SUD programs. Evaluation criteria will likely include vendor qualifications, treatment methodology, staff credentials, program effectiveness metrics, and proposed cost structures. Potential respondents should carefully review the full solicitation documents and prepare detailed proposals that comprehensively address the District's specific treatment service requirements.

While specific set-aside designations are not explicitly detailed in the provided information, District of Columbia procurement typically encourages participation from local, small, and disadvantaged business enterprises. Potential vendors should anticipate potential preferences for local providers or those with demonstrated community integration capabilities. The contract likely represents a significant investment in behavioral health infrastructure, potentially ranging from several hundred thousand to multiple million dollars annually, depending on service volume and treatment complexity. Existing treatment providers in the District of Columbia may have an advantage due to familiarity with local healthcare ecosystems and established referral networks. Respondents should be prepared to demonstrate robust clinical protocols, staff training programs, patient outcome tracking mechanisms, and the ability to integrate with existing municipal health and social service platforms. Vendors must also show capacity for comprehensive reporting, quality assurance, and compliance with District and federal substance abuse treatment regulations.